In a report released today, Timothy Daley from Wells Fargo maintained a Buy rating on Stevanato Group (STVN – Research Report), with a price target of $19.00. The company’s shares closed last Monday at $16.55, close to its 52-week low of $14.38.
Daley has an average return of 5.9% when recommending Stevanato Group.
According to TipRanks.com, Daley is ranked #5283 out of 7909 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stevanato Group with a $23.58 average price target.
The company has a one-year high of $29.18 and a one-year low of $14.38. Currently, Stevanato Group has an average volume of 305.7K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages.
Read More on STVN: